Lawmakers Must Step-in to Enact DTC List Price Disclosures, Additional Measures to Shine a Light on Big Pharma’s Pricing Practices Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Wednesday after the U.S. Court of Appeals for the District of Columbia Circuit upheld a ruling blocking the implementation of a measure […]
Drug Companies Must Forgo Mid-Year Price Increases While Millions of Americans Grapple With Historic Economic Uncertainty Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) announced Tuesday the launch of a campaign encouraging Big Pharma companies to suspend traditional mid-year price hikes while millions of Americans grapple with economic uncertainty caused by the COVID-19 […]
Coalition Applauds Positive Step from the Administration to Lower Insulin Prices, Encourages Additional Action to Hold Drug Companies Accountable Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) welcomed the announcement of a public-private partnership to help lower insulin prices for Medicare beneficiaries Tuesday. The move from the administration will create Medicare Part D […]
Brand Name Drug Companies Complete Sweep of Big Pharma Giants Who Beat Wall Street Expectations After Price Hikes In January In a final round of first quarter earnings reports, three more Big Pharma giants announced they surpassed earnings expectations after hiking prices on American patients. Amgen, AbbVie and Bristol-Myers Squibb all reported sky-high profits after […]
Drug Companies’ Focus on Most Profitable Treatments Hampers Pandemic Readiness Big Pharma neglected antiviral and vaccine research and development (R&D) for years in the run-up to the COVID-19 pandemic — despite frequent warnings from public health experts. The reason? The industry doggedly pursued, and pushed for public funding, into treatments viewed as more lucrative. In […]
Brand Name Drug Companies See Surging Profits After Hiking Prices Today, brand name drug giants AstraZeneca and GlaxoSmithKline (GSK) announced rising profits for the first quarter of 2020 – topping analysts’ expectations. AstraZeneca AstraZeneca reported a net profit of $780 million, up from $593 million in the same period a year earlier. Sales for the […]
Big Pharma Giants Continue to Outpace Expectations After Hiking Prices New first quarter earnings reports released this week from Big Pharma giants Merck, Novartis and Pfizer demonstrate yet again that price hikes continue to support cushy profits for brand name drug companies. All three pharmaceutical manufacturers beat Wall Street expectations for the first quarter of […]
Big Pharma Giant Sees Profits Soar After Price Hikes Big Pharma giant Sanofi topped earnings expectations while continuing to hike prices on the products in its portfolio, new earnings show. The brand name drug company keeps a trend alive that’s been consistent for three of the world’s largest pharmaceutical manufacturers who have reported earnings so […]
Jaguar Health Hikes Prices on HIV/AIDS Medication After Asking FDA to Expand Its Use for Coronavirus ICYMI, Jaguar Health, the manufacturer of brand name Mytesi, recently just tripled “the price of its lone FDA-approved drug, right after asking the federal government to expand the use of its drug to coronavirus patients,” Axios reports. At the […]
Brand Name Giant ‘Smashes’ Wall Street Expectations After Price Hikes on Diabetes, Cancer Medications New first quarter earnings reports released today from brand name giant Eli Lilly prove once again that repeated price hikes continue to support big time profits for Big Pharma. Eli Lilly bested Wall Street expectations after hiking prices on blockbuster on […]